Currently, the share price for Aarti Drugs Ltd. is delayed. Login to view live prices.
Aarti Drugs Ltd.
-- ( -- %) 1D
- Prev. Close487.50
- Upper Circuit585.00
- Lower Circuit390.00
Analyst Recommendations For Aarti Drugs Ltd.
As recommended by 1 analyst
Aarti Drugs Ltd.'s Info & Management
Aarti Drugs is engaged in the manufacturing and marketing in active Pharmaceutical Ingredients , Pharma Intermediates and Specialty Chemicals.
- Executive Director,Managing DirectorRashesh C Gogri
- Executive Director,Joint Managing DirectorHarshit M Savla
- Executive Director,Whole Time DirectorHarit P Shah
- Executive Director,Whole Time DirectorUday M Patil
- Chief Financial Officer,Chief Operating OfficerShri Adhish P. Patil
- Company Secretary,Compliance OfficerRushikesh Deole
FAQs on Aarti Drugs Ltd.
What is the share price of Aarti Drugs Ltd.?
Aarti Drugs Ltd. share price is ₹478.80 as of December 11, 2023, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the 52-week high and low of Aarti Drugs Ltd.?
The 52-week high and low of Aarti Drugs Ltd. is ₹645.00 and ₹313.90 respectively as of December 11, 2023, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).
What is the PE ratio of Aarti Drugs Ltd.?
The PE ratio of Aarti Drugs Ltd. is 24.90 as of December 12, 2023.The PE ratio measures the current share price relative to the earnings of the company for past 12 months (as of last reported period).
What is the PB ratio of Aarti Drugs Ltd.?
The trailing twelve month (TTM) PB ratio of Aarti Drugs Ltd. is 3.80 as of December 12, 2023. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Aarti Drugs Ltd.?
The Upper Circuit of Aarti Drugs Ltd. is ₹585. The Lower Circuit of Aarti Drugs Ltd. is ₹390.
What is the ROE of Aarti Drugs Ltd.?
Aarti Drugs Ltd. reported an ROE of 13.94% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Aarti Drugs Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Aarti Drugs Ltd., Promoter held 58.6%, the FII held 2.3%, DII held 5.3% and the public held 33.8% of the total shares.
How to buy Aarti Drugs Ltd. Share?
What is the fair value of Aarti Drugs Ltd.?
The fair value of Aarti Drugs Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.